Female pseudohermaphroditism due to congenital adrenal hyperplasia complicated by adenocarcinoma of the prostate and clear cell carcinoma of the endometrium

American Journal of Clinical Pathology

Volumn 106, Issue 5, 1996, Pages 660-664

  Winters, Jeffrey L ^a,e   Chapman, Phillip H ^b   Powell, Deborah E ^a   Banks, Evelyn R ^c   Allen, William R ^d   Wood Jr , David P ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

^c Lewis Gale Clinic   (United States)

^d Pattie A Clay Hospilal ^*  (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

21 hydroxylase deficiency; Clear cell carcinoma of the endometrium; Congenital adrenal hyperplasia; Prostatic adenocarcinoma; Pseudohermaphrodite

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CASE REPORT; CLEAR CELL CARCINOMA; CONGENITAL ADRENAL HYPERPLASIA; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PSEUDOHERMAPHRODITISM; RADIATION CARCINOGENESIS;

EID: 0029806511     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.5.660     Document Type: Article

References (23)

1. New MI. Steroid 21 -hydroxylase deficiency (congenital adrenal hyperplasia). Am J Med 1995;98(suppl 1A):2S-8S.
2. Zaviacic M. The adult human female prostate homologue and the male prostate gland: A comparative enzyme histochemical study. Acta Hislochem 1985;77:19-31.
3. Tepper SL, Jagirdar J, Heath D, Geller SA. Homology between the female paraurethral (Skene's) glands and the prostate. Arch Pathol Lab Med 1984;108:423-425.
4. Korenchevsky V. The female prostate gland and its reaction to male sexual compounds. J Physiol 1937;90:371-376.
5. Perloff WH, Conger KB, Levy LM. Female pseudohermaphroditism: A description of two unusual cases. J Clin Endocrinol Metab 1953;13:783-790.
6. Matheson WJ, Ward EM. Hormonal sex reversal in a female. Arch Dis Child 1954;29:22-27.
7. Schuhmann R. Angeborenes Andro-genitales Salzverlustsyndrom mit Entfaltung einer Prostata bei Weiblichem Saugling. Dtsch Med Wochenschr 1969;94:2229-2231.
8. Rosenberg B, Hendren WH, Crawford JD. Posterior urethrovaginal communication in apparent males with adrenocortical hyperplasia. N Engl J Med 1969;280:131-134.
9. Kiviat MD, Leonard JM. True prostatic tissue in a 46XX female with adrenogenital syndrome. Urology 1978;12:75-78.
10. Heyns CF, Rimington PD, Krager TF, Falck VG. Benign prostatic hyperplasia and uterine leiomyomas in a female pseudohermaphrodite: A case report. J Urol 1987;137:1245-1247.
11. Federman DD. Disorders of fetal endocrinology: Female pseudohermaphroditism. In: Abnormal Sexual Development: A Genetic and Endocrine Approach to Differential Diagnosis. Philadelphia: W.B. Saunders, 1967, pp 121-133.
12. Walsh PC, Migeon CJ. The phenotypic expression of selective disorders of male sexual differentiation. J Urol 1978;119:627-629.
13. Kellokumpa-Lehtinen P. Development of sexual dimorphism in the human urogenital sinus complex. Biol Neonate 1985;48: 157-167.
14. Svanholm H, Andersen DP, Rohl H. Tumour of female paraurethral duct immunohistochemical similarity with prostatic carcinoma. Virchows Arch [A] 1987;411:395-398.
15. Zaviacic M, Sidlo J, Borovsky M. Prostate specific antigen and prostate specific acid phosphatase in adenocarcinoma of Skene's paraurethral glands and ducts. Virchows Arch [A] 1993;423: 503-505.
16. Dodson MK, Ciby WA, Keeny G, Peterson MF, Podratz KC. Skene's gland adenocarcinoma with increased serum level of prostatic-specific antigen. Gynecol Oncol 1994;55:304-307.
17. Silverberg SC, DeGeorgi LS. Clear cell carcinoma of endometrium. Cancer 1973;31:1127-1140.
18. Kurman RJ, Scully RE. Clear cell carcinoma of the endometrium an analysis of 21 cases. Cancer 1976;37:872-882.
19. Photopulos GJ, Carney CN, Edelman DA, Hughes RR, Fowler WC, Walters LA. Clear cell carcinoma of the endometrium. Cancer 1979;43:1448-1456.
20. Christopherson WM, Alberhasky RC, Connelly PJ. Carcinoma of the endometrium IA: Clinicopathologic study of clear cell carcinoma and secretory carcinoma. Cancer 1982;49:1511-1523.
21. Webb GA, Lagios MD. Clear cell carcinoma of the endometrium. Am J Obstet Gynecol 1987;156:1486-1491.
22. Dallenbach-Hellweg G, Hahn U. Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (Tamoxifen) and gestagens. Int J Gynecol Pathol 1995;14: 7-15.
23. Silva EG, Tornos CS, Follen-Mitchell M. Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: The effects of Tamoxifen. Int J Gynecol Pathol 1994;13:248-258.